CN115192640A - Traditional Chinese medicine for circularly treating viral infection - Google Patents

Traditional Chinese medicine for circularly treating viral infection Download PDF

Info

Publication number
CN115192640A
CN115192640A CN202110391378.9A CN202110391378A CN115192640A CN 115192640 A CN115192640 A CN 115192640A CN 202110391378 A CN202110391378 A CN 202110391378A CN 115192640 A CN115192640 A CN 115192640A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
percent
viral infection
treating viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110391378.9A
Other languages
Chinese (zh)
Inventor
牛兴旺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110391378.9A priority Critical patent/CN115192640A/en
Publication of CN115192640A publication Critical patent/CN115192640A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A traditional Chinese medicine for circularly treating viral infection comprises the following raw materials in parts by weight: 4 to 7 percent of Chinese lacquer, 4 to 7 percent of chrysanthemum, 0.4 to 0.7 percent of jasmine flower, 0.4 to 0.7 percent of dried bitter gourd slice, 4 to 7 percent of denucleated red date, 4 to 7 percent of dandelion, 60 to 80 percent of egg and 4 to 7 percent of fried ginkgo seed; the invention combines with western medicine for intermittent taking for auxiliary treatment, has the effect of basically curing hepatitis B virus diseases and AIDS virus diseases, avoids the defects of drug resistance of taking Chinese and western medicines and incapability of stopping taking modern medicines, ensures that patients can live at normal lives and do not have infectivity any more.

Description

Traditional Chinese medicine for circularly treating viral infection
Technical Field
The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine for circularly treating viral infection.
Background
Hepatitis B virus is the causative agent of hepatitis B and belongs to the family of hepadnaviridae, which contains two genera, orthopeddnaviridae and avian hepadnaviridae, and it is the genus orthopeddnaviridae that causes infection in humans. The following mechanisms are responsible for the immunopathological impairment caused by HBV infection:
(1) The virus causes low immune response of the organism: when HBV is infected, the humoral antibody response to the outer membrane antigen is beneficial to eliminating virus particles in blood, and the cell immune response to the nucleocapsid and replicase antigen is beneficial to eliminating virus and damaging liver cells; after most of adults with normal immune function are infected with HBV, viruses can be eliminated through the coordination of natural immunity and adaptive immune response, HBV antibodies are generated, and if the viruses cannot be effectively eliminated, such as low immune function or inhibition, the viruses are continuously infected and replicated in liver cells to form chronic infection; HBV can also inhibit the immune function of the body after infecting a human body, and people with low immune function can not effectively eliminate virus, so that the infection is delayed and not healed and then becomes chronic; immune responses to viral antigens are associated with viral elimination and pathogenic mechanisms;
(2) The virus variation generates drug resistance: the persistent cause of HBV infection is usually the low immune response of the organism to the virus antigen, which is commonly seen in the immune escape after virus variation, and the virus can escape the specific immune response of the organism through the mechanism to make the infection chronic; the high variability of HBV is caused by the fact that the virus has a reverse transcription replication process, RNA polymerase and reverse transcriptase lack the correction function, and errors are easy to occur; HBV is easy to induce variation due to the influence of human body immunity pressure and anti-HBV drugs in the infection process, and after the HBV variation, viruses are difficult to remove and cause drug resistance, so that the curative effect of antiviral treatment is reduced; the variation of the S gene can cause HBsAg negative HBV variant infection, and the diagnosis escape appears; the synthesis of HBeAg is blocked by the gene variation of the front c/c region, and the HBeAg of a patient is negative, but the virus replication of the patient is not influenced, so that HBV DNA can be detected, and even the virus carrying capacity is higher; the variation of the gene in the P region can directly influence the antiviral treatment effect;
(3) Antibody-mediated immunopathological lesions: specific antibodies such as HBsAb, preS1-Ab and PreS2-Ab in serum after HBV infection can directly remove free viruses in blood circulation, but immune complexes formed by the antigen and the antibody can be deposited on glomerular basement membrane, joint synovial capsule and the like and activate complement to cause type III hypersensitivity; immune complexes can also be deposited in liver cells, causing liver capillary embolism, leading to acute liver necrosis, manifested as severe hepatitis; HBV infection can expose liver specific lipoprotein antigen, and can be used as autoantigen to induce organism to generate autoantibody, so as to damage liver cell by direct and indirect action;
(4) Cell-mediated immunopathological lesions: the immune cells can directly kill target cells of specific CTL by recognizing HLA-I molecules and virus antigens on cell membranes; cellular immunity is an important factor for thoroughly eliminating viruses, but for organisms, the cell is double-edged sword, excessive cellular immune reaction can cause large-area liver cell injury to cause severe hepatitis, but the virus cannot be effectively eliminated due to low cellular immune function, so that infection is chronic.
The three infection stages of the AIDS virus are as follows:
(1) Acute infection stage: the acute infection stage often occurs 2-4 weeks after the initial infection with the AIDS virus, and most patients in the stage have no serious clinical symptoms and can be relieved after lasting for 1-3 weeks; 15-20% of infected persons can have symptoms of fever, sweating, fatigue, myalgia, arthralgia, anorexia, rash, lymphadenectasis and the like within 2-6 weeks after infection, and generally enter an asymptomatic period after lasting for 3-14 days; no acute symptoms appear after the human is infected with the HIV;
(2) In the asymptomatic stage: the asymptomatic phase may occur after the acute phase, and the infected person may have no obvious acute phase symptoms and enter the asymptomatic phase directly, which lasts for 6-8 years, and the time is related to the number and type of the infected viruses, the infection route, the individual difference of the immune status of the body, the nutritional conditions, the living habits and other factors; in the asymptomatic phase, the immune system is impaired and the CD4+ T lymphocyte count gradually decreases as the hiv is continually replicating in infected individuals;
(3) In the AIDS stage: the aids stage is the last stage after infection with aids virus and is also the stage in which aids patients are located; the number of CD4+ T lymphocytes of the patient is less than 200/mu l, and the plasma viral load of the AIDS virus is obviously increased.
At present, the treatment of hepatitis B virus diseases and AIDS virus diseases mostly adopts a method of taking Chinese and western medicines, is easy to generate drug resistance and has the defect that the medicine can not be stopped.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine for circularly treating acute and chronic hepatitis B virus diseases and acute and chronic AIDS virus diseases aiming at the defects and the shortages of the prior art.
In order to achieve the purpose, the invention adopts the technical scheme that: the composite material comprises the following raw materials in parts by weight: 4-7% of Chinese lacquer, 4-7% of chrysanthemum, 0.4-0.7% of jasmine flower, 0.4-0.7% of dried bitter gourd slice, 4-7% of pitted red date, 4-7% of dandelion, 60-80% of egg and 4-7% of fried ginkgo seed;
further, the feed additive comprises the following raw materials in parts by weight: selecting 1-3g of lacquer, 1-3g of chrysanthemum, 0.1-0.3g of jasmine, 0.1-0.3g of dried bitter gourd slices, 1-3g of denucleated red dates, 1-3g of dandelion, 20-30g of eggs and 1-3g of fried ginkgo seeds;
furthermore, the eggs are boiled spiced tea eggs;
furthermore, the eggs are 1 boiled spiced tea egg, and after the boiled spiced tea egg is shelled, the boiled spiced tea egg is cut in the middle to be half;
further, the preparation method of the traditional Chinese medicine for circularly treating viral infection comprises the following steps:
1. selecting lacquer, chrysanthemum, jasmine, dried bitter gourd slices, denucleated red dates, dandelion, eggs and fried ginkgo in a weight ratio, cleaning the eight traditional Chinese medicine raw materials, sterilizing/disinfecting, cutting, cooking for 30 minutes, filtering, concentrating and preparing into oral liquid;
2. concentrating to obtain oral liquid, steaming for 30 min, concentrating, oven drying, and pulverizing to obtain Chinese medicinal granule or Chinese medicinal capsule.
The Chinese medicinal preparation can relieve cough, eliminate phlegm, treat edema, cough and asthma, treat scrofula, tinea and sore and other symptoms, prevent and treat epidemic parotitis, relieve pain and assist in treating tuberculosis and resisting bacteria; the chrysanthemum has the effects of dispelling wind, clearing heat, clearing liver, improving eyesight, calming liver yang, and clearing away heat and toxic materials; the jasmine tea has the effects of moistening lung, relieving cough, relieving spasm, tranquilizing, refreshing, improving endocrine, moistening skin color, regulating menstrual disorder, removing halitosis, and relieving mental fatigue; the dried bitter gourd slices have effects of clearing heat, invigorating qi, protecting organism, and reducing blood sugar; rutin contained in the denucleated red dates can soften blood vessels, so that the blood pressure is reduced, the effect of preventing and treating hypertension is achieved, and the effects of resisting allergy, removing fishy smell and strange taste, calming the heart and tranquilizing the mind, benefiting intelligence and strengthening brain and enhancing appetite can be achieved; the herba Taraxaci has effects of clearing away heat and toxic materials, caring skin, removing carbuncle, resolving hard mass, preventing and treating tumor, and resisting bacteria; the boiled spiced tea eggs have the effects of reminding, inhibiting bacteria, diminishing inflammation, promoting blood circulation, dredging collaterals and the like; the spiced tea eggs also contain rich nutrient substances such as protein, amino acid, cholesterol, lecithin, trace elements and the like; the roasted ginkgo has the effects of clearing heat, reducing pathogenic fire, promoting fluid production, quenching thirst and the like.
After the scheme is adopted, the invention has the beneficial effects that: the traditional Chinese medicine for circularly treating viral infection has the effect of basically curing hepatitis B virus diseases and AIDS virus diseases by matching with auxiliary treatment of intermittent administration of western medicines, avoids the defects that the medicine cannot be stopped after the traditional Chinese medicine and the western medicines are taken, enables patients to live normally and has no infectivity.
Detailed Description
The present invention is further described below.
Example (b): hepatitis B virus disease and AIDS virus disease are both transmissible and acute and chronic diseases.
The traditional Chinese medicine for circularly treating viral infection of the invention is divided into three treatment stages when treating hepatitis B virus diseases and AIDS virus diseases:
a first cyclical treatment phase: the traditional Chinese medicine for circularly treating viral infection comprises the following raw materials: selecting 3g of lacquer, 3g of chrysanthemum, 0.3g of jasmine tea, 0.3g of dried bitter gourd slices, 3g of pitted red dates and 3g of dandelion, taking 1 boiled spiced tea egg, cutting the middle part after shelling to take one half of the egg, and 3g of fried ginkgo; cleaning the above materials, sterilizing, cutting, steaming for 30 min, filtering, and concentrating to obtain oral liquid; concentrating to obtain oral liquid, steaming for 30 min, concentrating, oven drying, and pulverizing to obtain Chinese medicinal granule or Chinese medicinal capsule;
during treatment, the traditional Chinese medicine is matched with western medicine for taking, wherein the western medicine can adopt amoxicillin capsules, and other anti-inflammatory medicines can also be adopted; the dosage of the Chinese medicinal composition is 1 time in noon in 1 day; the Chinese medicine and the western medicine are taken 4 hours apart; western medicines are taken for 2 times after breakfast and supper, and are cyclically and discontinuously taken, so that the attack and consolidation treatment effect can be achieved, the Western medicines are suitable for the old, the middle-aged, the young and the children, and the pregnant women are forbidden to take; strengthening body exercise during administration, and prolonging the administration time of Chinese medicine and western medicine for 3-8 months in the first circulation treatment stage;
a second cyclical treatment phase: the traditional Chinese medicine for circularly treating viral infection comprises the following raw materials: selecting 2g of fructus aurantii immaturus, 2g of chrysanthemum, 0.2g of jasmine tea, 0.2g of dried bitter gourd slices, 2g of pitted red dates and 2g of dandelion, taking 1 boiled spiced tea egg, cutting the middle of the egg after shelling to take one half of the egg, and 2g of fried ginkgo seed; cleaning the above materials, sterilizing, cutting, steaming for 30 min, filtering, and concentrating to obtain oral liquid; concentrating to obtain oral liquid, steaming for 30 min, concentrating, drying, and pulverizing to obtain Chinese medicinal granule or Chinese medicinal capsule;
during treatment, the traditional Chinese medicine is matched with a small amount of western medicines, wherein the western medicines can adopt amoxicillin capsules, and other anti-inflammatory medicines can also be adopted; the Chinese medicine is taken 1 or 2 times a day after meals for circulation treatment, and is taken in the morning and at noon respectively, and a small amount of western medicine is taken after meals in the afternoon to achieve the effect of attack-consolidation treatment, and the western medicine is taken for seven days; it is suitable for the elderly, middle-aged, teenagers, and children, and is not suitable for pregnant women; the body is strengthened and exercised during the medicine taking period, the Chinese and western medicines can be taken as much as possible in the controlled disease stage and can be taken circularly and discontinuously, and the taking time is limited by the self constitution;
a third cyclical treatment phase: the traditional Chinese medicine for circularly treating viral infection comprises the following raw materials: selecting 1g of lacquer, 1g of chrysanthemum, 0.1g of jasmine tea, 0.1g of dried bitter gourd slices, 1g of pitted red dates and 2g of dandelion, taking 1 boiled spiced tea egg, cutting the middle of the egg after shelling to take one half of the egg, and 1g of fried ginkgo seed; cleaning the above materials, sterilizing, cutting, steaming for 30 min, filtering, and concentrating to obtain oral liquid; concentrating to obtain oral liquid, steaming for 30 min, concentrating, drying, and pulverizing to obtain Chinese medicinal granule or Chinese medicinal capsule; the Chinese medicine is taken 1 or 2 times after meals, respectively in the morning and at noon, and a small amount of western medicines are taken 1 time intermittently in the afternoon, and the medicine enters a rehabilitation period; it is suitable for the elderly, middle-aged, teenagers, and children, and is not suitable for pregnant women; the health can be strengthened during taking the medicine, and western medicines can not be taken when the patient enters the disease rehabilitation period.
The traditional Chinese medicine for circularly treating viral infection has the effects of killing and eliminating hepatitis B virus diseases, calming the liver, nourishing qi, soothing the liver, benefiting gallbladder and cutting off a copy chain, so that the liver function reaches the level of normal people, and an infection source is blocked; for AIDS virus diseases, the composition can improve the body immunity, block the virus propagation chain, and has the function of autoimmune reconstitution, thus breaking the drug resistance of western medicines taken for a long time; the circulating new therapy of Chinese and western medicine matching is adopted, the western medicine is taken after 4 hours of taking the traditional Chinese medicine, the mutual conflict of the traditional Chinese medicine and the western medicine can be effectively prevented, the drug resistance can be greatly reduced, the two diseases are treated together and recovered together, other western medicine anti-inflammatory medicines can be matched, amoxicillin capsules can be used as few as possible in one day, if an amoxicillin capsule allergic person exists, other western medicine anti-inflammatory medicines can also be replaced, and the medicine is stopped after 7 days of taking, and the western medicine is taken discontinuously. The Chinese medicine and western medicine are discontinuously matched in the acute period until rehabilitation, and the Chinese medicine can be used for long-time treatment in the chronic period, or the western medicine can be added to prevent drug resistance, so that the effect of healing is achieved.
After rehabilitation, the traditional Chinese medicines are intermittently taken every year, or western medicines are added to build up the body constitution of the human body. The traditional Chinese medicine of the invention can not generate drug resistance when being taken according to the dosage of the body along with the change of the body, and the preparation of the traditional Chinese medicine of the invention is practical, simple, efficient, reliable, low in cost, convenient for manufacturing in pharmaceutical factories, rich in raw material sources of the traditional Chinese medicine and low in price; during the period of taking the Chinese and western medicines, if the medicine is stopped midway, the limitation of disease rehabilitation is also influenced, but the aim of drug effect treatment can be quickly achieved by combining the circulating therapy Chinese medicine and the western medicine, and the defect that the medicine cannot be stopped when the medicine is taken is overcome.
After most patients are treated by the traditional Chinese medicine, the examination and test report in the hospital shows normal, the next generation is not infected, the body work is not influenced, and the couple can live normally.
The above description is only for the purpose of illustrating the technical solutions of the present invention and not for the purpose of limiting the same, and other modifications or equivalent substitutions made by those skilled in the art to the technical solutions of the present invention should be covered within the scope of the claims of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (5)

1. The traditional Chinese medicine for circularly treating viral infection is characterized by comprising the following raw materials in parts by weight: 4-7% of Chinese lacquer, 4-7% of chrysanthemum, 0.4-0.7% of jasmine, 0.4-0.7% of dried bitter gourd slices, 4-7% of pitted red dates, 4-7% of dandelion, 60-80% of eggs and 4-7% of fried ginkgo seeds.
2. The traditional Chinese medicine for circularly treating viral infection according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 1-3g of lacquer, 1-3g of chrysanthemum, 0.1-0.3g of jasmine, 0.1-0.3g of dried bitter gourd slices, 1-3g of denucleated red dates, 1-3g of dandelion, 20-30g of eggs and 1-3g of fried ginkgo seeds.
3. The traditional Chinese medicine for circularly treating viral infection according to claim 1 or 2, wherein the egg is a boiled spiced tea egg.
4. The traditional Chinese medicine for circularly treating viral infection as claimed in claim 3, wherein the egg is prepared from 1 boiled spiced tea egg, and the boiled spiced tea egg is cut in the middle after being shelled.
5. The traditional Chinese medicine for cyclically treating viral infection according to claim 4, wherein the preparation method comprises the following steps:
1. selecting lacquer, chrysanthemum, jasmine, dried bitter gourd slices, denucleated red dates, dandelion, eggs and fried ginkgo in a weight ratio, cleaning the eight traditional Chinese medicine raw materials, sterilizing/disinfecting, cutting, cooking for 30 minutes, filtering, concentrating and preparing into oral liquid;
2. concentrating to obtain oral liquid, steaming for 30 min, concentrating, drying, pulverizing, and making into Chinese medicinal granule or capsule.
CN202110391378.9A 2021-04-12 2021-04-12 Traditional Chinese medicine for circularly treating viral infection Pending CN115192640A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110391378.9A CN115192640A (en) 2021-04-12 2021-04-12 Traditional Chinese medicine for circularly treating viral infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110391378.9A CN115192640A (en) 2021-04-12 2021-04-12 Traditional Chinese medicine for circularly treating viral infection

Publications (1)

Publication Number Publication Date
CN115192640A true CN115192640A (en) 2022-10-18

Family

ID=83571668

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110391378.9A Pending CN115192640A (en) 2021-04-12 2021-04-12 Traditional Chinese medicine for circularly treating viral infection

Country Status (1)

Country Link
CN (1) CN115192640A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1266709A (en) * 1999-03-16 2000-09-20 杨清雪 Medicine for dropping drug and preparing process thereof
CN1403140A (en) * 2002-10-11 2003-03-19 季长春 Medicine for treating acute and chronic hepatitis B

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1266709A (en) * 1999-03-16 2000-09-20 杨清雪 Medicine for dropping drug and preparing process thereof
CN1403140A (en) * 2002-10-11 2003-03-19 季长春 Medicine for treating acute and chronic hepatitis B

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HENGUHA8UGUF0K: "重用泽漆治乙肝，疗效颇佳（很值得一看，可参考、借鉴、研究）" *
京九晚报: "商丘发明家成功获得中国发明专利申请号" *
张英泽: "乙肝可以吃红枣吗？" *
无: "2020年治疗乙肝的相关偏方有哪些" *
遗***: "乙型病毒性肝炎可不可以吃茶叶蛋？" *

Similar Documents

Publication Publication Date Title
CN110072517A (en) The method for treating the viral hepatitis type b that how there is drug resistance to liver
Shubhashree et al. Preventive strategies to combat infections–a review of traditional practices and Ayurveda concepts
CN103393908B (en) Product for treating systemic lupus erythematosus and rheumatism and preparation method thereof
CN101306138A (en) Chinese traditional injection preparation for treating chest stuffiness and pains and its preparation method
CN115192640A (en) Traditional Chinese medicine for circularly treating viral infection
CN108042669A (en) A kind of Chinese medicine for treating acute toothache and preparation method thereof
CN104147270B (en) Treat the Chinese medicine composition of oxyhepatitis
JP4121957B2 (en) Indigo preparation and its use in preventing or treating human immunodeficiency virus infection
CN110946950A (en) A Chinese medicinal composition for treating senile vascular dementia, and its preparation method
US6582733B1 (en) Composition for the treatment of hepatitis including HCV
CN103585212B (en) The application of Dorema ammoniacum resin extract in preparation treatment AIDS-treating medicine
CN104398677B (en) A kind of tartary buckwheat general flavone and Gynostemma Pentaphyllum compound
CN104173927B (en) A kind of Chinese medicine composition for treating apoplexy sequela and preparation method thereof
CN109091598A (en) A kind of oral nursing liquid and its processing technology
CN103816199B (en) A kind of anti-duck virus hepatitis Chinese medical extract compound
CN108042668A (en) A kind of Chinese medicine for treating acute toothache and preparation method thereof
CN108079113A (en) A kind of pharmaceutical composition for treating the postpartum deficiency of blood and preparation method thereof
CN102805810A (en) Chinese medicinal preparation for treating acquired immune deficiency syndrome (AIDS) and preparation method thereof
KR102590559B1 (en) Composition comprising slugs extract as an active ingredient for preventing, improving or treating insomnia
CN107569565A (en) A kind of Chinese medicinal lotion for treating tinea pedis and preparation method thereof
CN102462785A (en) Medicinal composition for treating acquired immune deficiency syndrome viruses and preparation method thereof
Lee et al. Flu for you? The common cold, influenza, and traditional medicine
CN101244218A (en) Chinese medicinal herb oral administration particle for treating oxyhepatitis
Pathak et al. Relevance of Ayurveda in Indian Scenario for Management of Pandemic Covid-19–A
WO2022126255A1 (en) Antioxidant nutritional supplement for immune system support

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20221018

RJ01 Rejection of invention patent application after publication